Japan’s IP High Court overturned the JPO’s rejection of a Riken Technos patent for transparent projection screen coatings, holding the patent office failed to explain why a skilled person would have selected the claimed resin from known alternatives.
Japan’s Intellectual Property High Court overturned the JPO’s invalidation of a key Broad Institute CRISPR patent, ruling that the institutions could validly claim priority from earlier U.S. filings despite a dispute over ownership of those priority rights.
The Japan Intellectual Property High Court reversed the Tokyo District Court and held that a generic narlfrafen hydrochloride (nalfurafine) anti-itch product infringes Toray’s term-extended pharmaceutical use patent on Remitch, awarding the patentee approximately ¥21.7 billion (~US$140 million